Naslov
HA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
(EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes)

Autori
Van de Loosdrecht, Arjan A. ; Mandac Smoljanović, Inga

Izvornik
HemaSphere (2572-9241) 6 (2022), 3; 1-2

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
MDS

Sažetak
European Hematology Association (EHA) and European Society for Medical Oncology (ESMO) recently agreed to collaborate on the production of European Guidelines for different hematological malignancies. As a first step, a number of completed guidelines have been reviewed by the corresponding EHA Scientific Working Groups in a standardized review process. The ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up for myelodysplastic syndromes (MDS) published on November 19, 2020 (https://www. annalsofoncology.org/article/S0923-7534(20)43129- 1/fulltext) in accordance with the ESMO standard operating procedures for clinical practice guidelines development were recently endorsed by the EHA

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA